6.2 Biofilm, Colonization, Culture, and Antimicrobial Traps
Key Takeaways
- Biofilm is tested as a reason chronic wounds stall despite ordinary cleansing and dressing changes.
- Colonization, critical colonization, local infection, and systemic infection are not interchangeable terms on the exam.
- Cultures are most useful when the specimen is obtained from cleansed viable tissue and interpreted with clinical findings.
- The exam trap is using topical or systemic antimicrobials indefinitely without debridement decisions, cause control, or a reevaluation endpoint.
Biofilm changes the chronic wound logic
Biofilm is a structured microbial community encased in a self-produced extracellular matrix that adheres to the wound bed and resists antibiotics, antiseptics, and host immune cells. On the WCC exam it appears not as microbiology trivia but as a pattern: a chronic wound that stalls, has recurrent slough, becomes overly inflammatory, or improves briefly after care and then declines.
Biofilm can re-form within 24-72 hours of disruption, which is why repeated mechanical disruption (debridement, cleansing) immediately followed by an antimicrobial cover -- a strategy sometimes called "step-down, step-up" -- is the tested approach rather than antimicrobials applied over an undisturbed bed. A single debridement is rarely enough; serial maintenance debridement keeps the bioburden suppressed long enough for the wound to advance.
The terminology ladder must be precise. Colonization means microorganisms are present and replicating without a host response. Critical colonization (covert local infection) means bioburden is high enough to impair healing without classic overt signs. Local infection shows a harmful host response confined to the wound and periwound. Spreading infection extends into surrounding tissue, and systemic infection affects the patient beyond the wound.
| Concept | Exam clue | Better response |
|---|---|---|
| Colonization | Stable chronic wound, no new inflammatory signs | Do not treat the culture; continue routine care |
| Biofilm / critical colonization | Recurrent slough, stalled measurements, dull friable granulation, quick relapse | Cleanse, debride per pathway, apply antimicrobial dressing, reassess in 2 weeks |
| Local infection | New pain, odor after cleansing, purulence, friable tissue | Notify per policy; select local antimicrobial if ordered |
| Spreading infection | Redness, warmth, swelling beyond the wound edge | Escalate to provider promptly |
| Systemic infection | Fever, chills, confusion, abnormal labs, decline | Urgent medical evaluation pathway |
Wound bed preparation and the TIME model
Biofilm management lives inside wound bed preparation, often taught with the TIME framework: Tissue (debride nonviable tissue), Infection/inflammation (control bioburden), Moisture balance (manage exudate), and Edge advancement (assess epithelial migration). The exam rewards candidates who debride and reassess rather than rotating products blindly. A 2-week antimicrobial "challenge" with a defined endpoint is a defensible answer; indefinite use is not.
Applied scenario: a pressure injury has stalled for four weeks with recurrent thin slough and no fever. The best answer is not systemic antibiotics from a swab. Reassess pressure relief, moisture, nutrition, wound bed preparation, debridement need, and whether a quantitative tissue culture or provider evaluation is indicated. If systemic signs appear, the answer escalates.
Culture technique and antimicrobial stewardship
Culture technique is an exam favorite. A swab of old drainage sitting on the dressing is poor evidence and reflects surface colonizers. When a culture is ordered for a clinically infected wound, the tested preference is the Levine technique: cleanse and debride first, then rotate a swab over a 1-cm-square area of viable tissue with enough pressure to express fluid. Tissue biopsy or needle aspiration is the reference standard in some settings, but the WCC candidate should not invent procedures beyond role authority.
Antimicrobial stewardship means using silver, iodine (cadexomer or povidone), polyhexamethylene biguanide (PHMB), or medical-grade honey for a specific indication, for a defined reassessment period, and in coordination with orders. Indefinite use without a goal delays the real fix. If pressure, edema, ischemia, or hyperglycemia remains uncontrolled, the wound keeps failing despite antimicrobial dressings.
Two mirror traps: equating biofilm with automatic systemic infection (biofilm drives chronic local inflammation without fever), and using a negative culture to dismiss worsening cellulitis (clinical findings still drive escalation). On test day, read every culture or biofilm question by asking three things: what changed, how severe is the host response, and what underlying cause remains untreated.
Cleansing solutions and the anti-biofilm sequence
The exam may ask which cleanser fits which goal. Normal saline and potable water are non-cytotoxic and fine for routine, clean, healing wounds. For wounds with suspected biofilm or critical colonization, surfactant-based cleansers and antiseptic solutions such as polyhexamethylene biguanide (PHMB) or hypochlorous acid help loosen and lower bioburden. Older cytotoxic agents (full-strength povidone-iodine, hydrogen peroxide, Dakin's at high strength, acetic acid) damage fibroblasts and are reserved for short, specific indications rather than routine cleansing.
The defensible anti-biofilm sequence is cleanse, debride to disrupt the matrix, apply an antimicrobial dressing, and reassess at a defined interval -- not antiseptic soaks alone.
Quantitative thresholds and documentation
When the stem provides laboratory data, recall that a tissue bacterial load classically reported as greater than 10 to the fifth (100,000) organisms per gram of tissue is associated with impaired healing, though beta-hemolytic streptococci can impair healing at far lower counts. This explains why a wound can be "infected" clinically with a modest colony count, and why clinical judgment outranks a single number. Document the rationale for any antimicrobial: the suspected level on the infection continuum, the wound bed preparation performed, the product and its planned endpoint (commonly a 2-week trial), and the next measurement date.
WCC questions consistently reward candidates who set a concrete reassessment point over those who make an open-ended product change.
A chronic wound culture taken from old drainage on the dressing grows bacteria, but the wound is stable with no new inflammatory signs. What is the best WCC interpretation?
Which pattern most suggests biofilm as a contributor to stalled healing?
What is the main antimicrobial stewardship trap in WCC scenarios?